Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,792 | 1,037 | 5,361 | 7,091 | 7,839 |
| Receivables | 643 | 271 | 627 | 1,256 | 3,303 |
| TOTAL | $11,513 | $1,676 | $6,437 | $9,092 | $12,091 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 9 | 13 | 15 |
| Intangibles | 1,978 | 2,079 | 2,180 | 2,281 | 2,382 |
| Other Non-Current Assets | 40 | 60 | 265 | 190 | 97 |
| TOTAL | $2,018 | $2,138 | $2,454 | $2,484 | $2,494 |
| Total Assets | $13,531 | $3,814 | $8,890 | $11,576 | $14,585 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,079 | 1,813 | 1,747 | 2,122 | 1,380 |
| TOTAL | $1,079 | $1,833 | $1,822 | $2,141 | $1,459 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 20 | 44 | 68 |
| TOTAL | $N/A | $N/A | $20 | $44 | $68 |
| Total Liabilities | $1,079 | $1,833 | $1,842 | $2,184 | $1,526 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,334 | 3,468 | 3,165 | 2,766 | 1,932 |
| Common Shares | 54,515 | 47,236 | 46,643 | 42,473 | 34,888 |
| Retained earnings | -65,911 | -58,589 | -52,419 | -44,045 | -26,496 |
| Other shareholders' equity | -166 | -243 | -215 | -214 | -205 |
| TOTAL | $12,452 | $1,981 | $7,049 | $9,391 | $13,058 |
| Total Liabilities And Equity | $13,531 | $3,814 | $8,890 | $11,576 | $14,585 |